文献速递心脑血管急症重症综合管理与镇静镇痛

心脏骤停后脑CT的自动评估——一项观察性衍生/验证队列研究

Automated Assessment of Brain CT After Cardiac Arrest-An Observational Derivation/Validation Cohort Study.
PubMed 文献 · Crit Care Med · 2021-01-01
一句话结论心脏骤停后>24小时脑CT自动计算的灰白质比值(GWR_si)以<1.10为阈值预测不良神经结局特异度100%,但敏感度仅49%(衍生队列)。

该观察性衍生/验证队列研究纳入433例心脏骤停患者、共516次脑CT,用脑图谱配准自动分解CT并量化灰白质比值(GWR_si,壳核/内囊后肢)。出院时以脑功能分级(CPC)评定结局,不良结局定义为死亡或无反应觉醒综合征/昏迷。心脏骤停后>24小时CT的GWR_si预测不良结局AUC为0.86(95%CI 0.80-0.93),阈值<1.10时特异度100%(95%CI 87-100%,衍生;88-100%,验证),敏感度49%(95%CI 36-58%,衍生)和38%(95%CI 27-50%,验证);24小时内CT的敏感度与AUC更低。作者认为自动GWR是有前景的工具,基底节层面预测最佳,>24小时CT敏感度明显提高。

要点

  • 心脏骤停后>24小时脑CT自动GWR_si(壳核/内囊后肢)预测不良结局AUC 0.86(95%CI 0.80-0.93),验证队列表现相似。
  • GWR_si<1.10预测不良结局(CPC 4-5)特异度100%(95%CI 87-100%,衍生;88-100%,验证),敏感度49%(衍生)与38%(验证)。
  • 24小时内完成的CT敏感度与AUC均低于>24小时的CT。
  • 不良结局患者灰质区域放射密度显著更低。
  • 自动量化可避免手动放置感兴趣区的误差与评估者间变异。

适用人群与场景

  • 心脏骤停后入住ICU、于骤停后10天内接受脑CT的患者,共433例(516次CT)。
  • 研究在具备循环骤停中心的大型学术医院ICU进行。

诊断标准与关键阈值

  • 不良结局定义:出院时脑功能分级(CPC)4-5级,即死亡或无反应觉醒综合征/昏迷。
  • 预测阈值:自动GWR_si(壳核/内囊后肢)<1.10预测不良结局。

研究设计与关键结果

  • 观察性衍生/验证队列研究,433例心脏骤停患者共516次脑CT(衍生队列n=309,验证队列n=207)。
  • 心脏骤停后>24小时CT的GWR_si预测不良结局AUC 0.86(95%CI 0.80-0.93),验证队列表现相似。
  • 阈值<1.10时特异度100%(95%CI 87-100%,衍生;88-100%,验证),敏感度49%(95%CI 36-58%,衍生)和38%(95%CI 27-50%,验证),均针对>24小时的CT。
  • 24小时内CT的敏感度与AUC更低。
  • 不良结局患者灰质区域放射密度显著低于结局良好者。

证据类型、等级与局限

  • 证据类型:观察性衍生/验证队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为自动GWR是有前景的工具,可在心脏骤停后预测不良神经结局,具高特异度、低至中等敏感度。
  • 作者指出基底节层面的GWR预测表现最佳,且>24小时CT的敏感度明显提高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Prognostication of outcome is an essential step in defining therapeutic goals after cardiac arrest. Gray-white-matter ratio obtained from brain CT can predict poor outcome. However, manual placement of regions of interest is a potential source of error and interrater variability. Our objective was to assess the performance of poor outcome prediction by automated quantification of changes in brain CTs after cardiac arrest.

DESIGN: Observational, derivation/validation cohort study design. Outcome was determined using the Cerebral Performance Category upon hospital discharge. Poor outcome was defined as death or unresponsive wakefulness syndrome/coma. CTs were automatically decomposed using coregistration with a brain atlas.

SETTING: ICUs at a large, academic hospital with circulatory arrest center.

PATIENTS: We identified 433 cardiac arrest patients from a large previously established database with brain CTs within 10 days after cardiac arrest.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Five hundred sixteen brain CTs were evaluated (derivation cohort n = 309, validation cohort n = 207). Patients with poor outcome had significantly lower radiodensities in gray matter regions. Automated GWR_si (putamen/posterior limb of internal capsule) was performed with an area under the curve of 0.86 (95%-CI: 0.80-0.93) for CTs taken later than 24 hours after cardiac arrest (similar performance in the validation cohort). Poor outcome (Cerebral Performance Category 4-5) was predicted with a specificity of 100% (95% CI, 87-100%, derivation; 88-100%, validation) at a threshold of less than 1.10 and a sensitivity of 49% (95% CI, 36-58%, derivation) and 38% (95% CI, 27-50%, validation) for CTs later than 24 hours after cardiac arrest. Sensitivity and area under the curve were lower for CTs performed within 24 hours after cardiac arrest.

CONCLUSIONS: Automated gray-white-matter ratio from brain CT is a promising tool for prediction of poor neurologic outcome after cardiac arrest with high specificity and low-to-moderate sensitivity. Prediction by gray-white-matter ratio at the basal ganglia level performed best. Sensitivity increased considerably for CTs performed later than 24 hours after cardiac arrest.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kenda M, Scheel M, Kemmling A, et al. Automated Assessment of Brain CT After Cardiac Arrest-An Observational Derivation/Validation Cohort Study. Crit Care Med. 2021. PMID: 34374503. doi:10.1097/CCM.0000000000005198

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。